MELISSA DEPERSIS: Open Payments
NPI 1134673601 · WINDSOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 20 payments from 8 companies in 2025. Trend: 2023 $54 · 2024 $422 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| PFIZER INC. | 4 | $73 |
| ABBVIE INC. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Lilly USA, LLC | 1 | $29 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: VRAYLAR, VOQUEZNA, SHINGRIX, AIRSUPRA, BREZTRI, ELIQUIS, MOUNJARO, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
